Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 20/20 | 0.98 |
| ▸ | KCNA5 | P22460 | 14/20 | 0.98 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.98 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.98 |
| ▸ | LMNA | P02545 | 1/20 | 0.98 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.98 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.98 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.98 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.98 |
| ▸ | TSHR | P16473 | 1/20 | 0.98 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.98 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.98 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.98 |
| ▸ | BLM | P54132 | 1/20 | 0.98 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.98 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.98 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.98 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.98 |
| ▸ | KCNA1 | Q09470 | 3/20 | 0.77 |
| ▸ | KCNA4 | P22459 | 2/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29386652 | 0.99 | KCNA3 (1.00) | KCNA3KCNA5KDM4EALDH1A1LMNA | |
| SCHEMBL2801777 | 0.99 | KCNA3 (1.00) | KCNA3KCNA5KDM4EALDH1A1LMNA | |
| SCHEMBL2801814 | 0.95 | KCNA3 (0.93) | KCNA3KCNA5KDM4EALDH1A1LMNA | |
| SCHEMBL2798087 | 0.92 | KCNA3 (0.86) | KCNA3KCNA5KDM4EALDH1A1LMNA | |
| SCHEMBL2585444 | 0.88 | KCNA3 (1.00) | KCNA3KCNA5KDM4EALDH1A1LMNA | |
| SCHEMBL2579687 | 0.87 | KCNA3 (1.00) | KCNA3KCNA5KDM4EALDH1A1LMNA | |
| SCHEMBL29410610 | 0.87 | KCNA3 (1.00) | KCNA3KCNA5KDM4EALDH1A1LMNA | |
| SCHEMBL2585454 | 0.87 | KCNA3 (1.00) | KCNA3KCNA5KDM4EALDH1A1LMNA | |
| SCHEMBL2586220 | 0.85 | KCNA3 (1.00) | KCNA3KCNA5KDM4EALDH1A1LMNA | |
| SCHEMBL2583446 | 0.84 | KCNA3 (1.00) | KCNA3KCNA5KDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210393857-A1 | SMALL MOLECULE DRUGS AND METHODS TO ACCELERATE OSSEOINTEGRATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-12-23 | — | — | US | claimed |
| EP-3876871-A1 | SMALL MOLECULE DRUGS AND METHODS TO ACCELERATE OSSEOINTEGRATION | The Regents of the University of California (US) | 2021-09-15 | — | — | EP | claimed |
| US-7772408-B1 | Substituted 5-alkoxypsoralens as inhibitors of potassium channel activity in lymphocytes and other cells | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-08-10 | — | — | US | claimed |
| WO-2025082731-A1 | INTRANASAL FORMULATIONS FOR TREATING OBSTRUCTIVE SLEEP APNEA | MOSANNA THERAPEUTICS AG (CH) | 2025-04-24 | — | — | WO | disclosed |
| US-20210393857-A1 | SMALL MOLECULE DRUGS AND METHODS TO ACCELERATE OSSEOINTEGRATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-12-23 | — | — | US | disclosed |
| US-20210393857-A1 | SMALL MOLECULE DRUGS AND METHODS TO ACCELERATE OSSEOINTEGRATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-12-23 | — | — | US | disclosed |
| EP-3876871-A1 | SMALL MOLECULE DRUGS AND METHODS TO ACCELERATE OSSEOINTEGRATION | The Regents of the University of California (US) | 2021-09-15 | — | — | EP | disclosed |
| US-7772408-B1 | Substituted 5-alkoxypsoralens as inhibitors of potassium channel activity in lymphocytes and other cells | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-08-10 | — | — | US | disclosed |
| US-7772408-B1 | Substituted 5-alkoxypsoralens as inhibitors of potassium channel activity in lymphocytes and other cells | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-08-10 | — | — | US | disclosed |
| US-7772408-B1 | Substituted 5-alkoxypsoralens as inhibitors of potassium channel activity in lymphocytes and other cells | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210393857-A1 | SMALL MOLECULE DRUGS AND METHODS TO ACCELERATE OSSEOINTEGRATION | PER2, NCOR2, NR4A2 | KCNA3 3196/4885KCNA5 3370/4885KDM4E 1437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.